Lynn Francesconi to Humans
This is a "connection" page, showing publications Lynn Francesconi has written about Humans.
Connection Strength
0.144
-
Hatcher-Lamarre JL, Sanders VA, Rahman M, Cutler CS, Francesconi LC. Alpha emitting nuclides for targeted therapy. Nucl Med Biol. 2021 Jan; 92:228-240.
Score: 0.035
-
Deri MA, Ponnala S, Kozlowski P, Burton-Pye BP, Cicek HT, Hu C, Lewis JS, Francesconi LC. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET. Bioconjug Chem. 2015 Dec 16; 26(12):2579-91.
Score: 0.025
-
Thompson S, Ballard B, Jiang Z, Revskaya E, Sisay N, Miller WH, Cutler CS, Dadachova E, Francesconi LC. 166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel. Nucl Med Biol. 2014 Mar; 41(3):276-81.
Score: 0.022
-
Ballard B, Jiang Z, Soll CE, Revskaya E, Cutler CS, Dadachova E, Francesconi LC. In vitro and in vivo evaluation of melanin-binding decapeptide 4B4 radiolabeled with 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma. Cancer Biother Radiopharm. 2011 Oct; 26(5):547-56.
Score: 0.019
-
MacPherson DS, Fung K, Cook BE, Francesconi LC, Zeglis BM. A brief overview of metal complexes as nuclear imaging agents. Dalton Trans. 2019 Oct 07; 48(39):14547-14565.
Score: 0.008
-
Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. a-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1. J Nucl Med. 2018 06; 59(6):878-884.
Score: 0.007
-
Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. a-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 2. J Nucl Med. 2018 07; 59(7):1020-1027.
Score: 0.007
-
Cristaudo A, Francesconi L, Ambrifi M, Frasca M, Cavallotti C, Sperduti E. Efficacy of an emollient dermoprotective cream in the treatment of elderly skin affected by xerosis. G Ital Dermatol Venereol. 2015 Jun; 150(3):297-302.
Score: 0.006
-
Deri MA, Zeglis BM, Francesconi LC, Lewis JS. PET imaging with 8?Zr: from radiochemistry to the clinic. Nucl Med Biol. 2013 Jan; 40(1):3-14.
Score: 0.005
-
Acetoso M, Francesconi L. [Evaluation of immune status in rubella infection in the pregnant population of the U.S.L. 3 of Pesaro 1981-1985]. Quad Sclavo Diagn. 1986 Sep; 22(3):283-90.
Score: 0.003
-
Efange SM, Tu Z, von Hohenberg K, Francesconi L, Howell RC, Rampersad MV, Todaro LJ, Papke RL, Kung MP. 2-(2-Piperidyl)- and 2-(2-pyrrolidyl)chromans as nicotine agonists: synthesis and preliminary pharmacological characterization. J Med Chem. 2001 Dec 20; 44(26):4704-15.
Score: 0.002
-
Ohmomo Y, Francesconi L, Kung MP, Kung HF. New conformationally restricted 99mTc N2S2 complexes as myocardial perfusion imaging agents. J Med Chem. 1992 Jan; 35(1):157-62.
Score: 0.001
-
Abate L, Croci F, Francesconi L, Bayeli PF. [A retrospective clinico-endoscopic study of colorectal cancer. Personal case histories]. Minerva Med. 1989 Mar; 80(3):249-53.
Score: 0.001
-
Bayeli P, Abate L, Francesconi L, Lio R, Cetta F, Tanzini G. [Mesenteric fibrosis. Apropos of 1 of our cases]. Minerva Dietol Gastroenterol. 1988 Oct-Dec; 34(4):273-6.
Score: 0.001